Pinetree Therapeutics
Latest round
- Series B
Last raised
- Oct 2025
Total raised
- $71M
Investors
- 14
About Pinetree Therapeutics
Founded in 2019 and based in Massachusetts, US, Pinetree Therapeutics, Inc. operates as a preclinical stage biotechnology company that uses TAER-TAB technology, a bispecific antibody (bsAb) that targets cancer cells in the lungs, breasts, pancreas, cervix, colon, kidneys, ovaries, stomach, and others. In October 2025, Pinetree Therapeutics, Inc. The company's therapeutical services are based on technology TAER-TAB (Tumour Associated Essential Receptor Targeting Antibody), a platform technology that can be used to create multifunctional antibodies directed against multiple receptor targets on cancer cells, and ViTRAP (Virus Targeting Recombinant Agent Platform), an antiviral technology which can design discrete, disease-specific, biologic therapeutics for many diseases with unmet needs on a global basis.
Who invested in Pinetree Therapeutics
14 investors across 2 rounds
See all investors in Pinetree Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Pinetree Therapeutics
Who invested in Pinetree Therapeutics?
Pinetree Therapeutics has 14 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Pinetree Therapeutics raised?
Pinetree Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Pinetree Therapeutics last raise money?
Pinetree Therapeutics's most recent round on record is a Series B, in Oct 2025.
What does Pinetree Therapeutics do?
Founded in 2019 and based in Massachusetts, US, Pinetree Therapeutics, Inc.
Where is Pinetree Therapeutics headquartered?
Pinetree Therapeutics is headquartered in Cambridge, US.
Which VCs invest in companies like Pinetree Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Pinetree Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Pinetree Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.